Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Board/Management Information 2020

Feb 14, 2020

60507_rns_2020-02-14_6152ccbd-76a1-42f5-a040-8292d3afae36.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Pfizer Limited

The Capital, 1802 I 1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051 . Tel: +91 22 6693 2000 Fax : +91 22 2654 0274

February 14, 2020

The Corporate Re lationship Dept. BSE Limited 1st Floor, P.J.Towers Dalal Street, Fort Mumbai - 400 001 Scrip Code: 500680

Manager, Listing Dept. National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Symbol: PFIZER

Dear Sirs,

Sub: Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Appointment of Mr. Samir Kazi as an Executive Director.

Pursuant to regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company at their meeting held today appointed Mr. Samir Kazi (DIN: 07184083) as Additional Director of the Company, designated as Executive Director, Legal with effect from February 14, 2020 for a period of 5 years. The appointment of Mr. Samir Kazi wil l be subject to the approval of shareholders at the ensuing Annual General Meeting of the Company.

Mr. Samir Kazi is a lawyer with over 20 years of rich legal experience. Mr. Samir Kazi earned his Bachelor's of Law degree from the University of Mumbai in the year 1999.

Mr. Samir Kazi has represented various clients in a broad range of litigation disputes and transactional matters, handled complex commercial and business litigation and specialized in alternative dispute resolution. Mr. Samir Kazi's core competencies includes Corporate Laws, Intellectual Property laws, Corporate Governance, Cross Border transactions, Mergers & Acquisitions, Joint Ventures, Amalgamations and Regulatory laws amongst various other areas of expertise.

Mr. Samir Kazi is a part of Pfizer Limited Leadership team and is responsible for providing quality legal advice, including inputs on matters relating to industrial bodies, governance, compliance and mergers & acquisitions, establishment of strategic alliances, partnerships and relationships with internal & external clients.

Mr. Samir Kazi started his career with an illustrious law firm in Mumbai - Mulla & Mulla & Craigie Blunt & Caroe, where Mr. Samir Kazi practiced for over 7 years before taking up in-house law practice. Thereafter, Mr. Samir Kazi was a Legal advisor to the Hinduja Group India Limited, before being associated with Pfizer Limited since 2007.

-eaN : L2'<231 MH19 50PLC008311

121 [email protected]

~ www.pfizerindia.com

Mr. Samir Kazi does not hold any shares in the Company. None of the Directors are related to Mr. Samir Kazi. Mr. Samir Kazi is not debarred or disqualified from holding the office of Director by virtue of any order from MCA/SEBI or any such statutory authority.

We request you to kindly take the above on record.

Thanking you,

Yours truly, For Pfizer Limited

Company Secretary